Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) Sees Large Drop in Short Interest

Acura Pharmaceuticals, Inc. (OTCMKTS:ACURGet Rating) saw a significant drop in short interest in March. As of March 31st, there was short interest totalling 39,800 shares, a drop of 34.3% from the March 15th total of 60,600 shares. Based on an average trading volume of 9,700 shares, the short-interest ratio is currently 4.1 days.

ACUR opened at $0.50 on Friday. Acura Pharmaceuticals has a fifty-two week low of $0.29 and a fifty-two week high of $0.75. The stock has a market capitalization of $32.37 million, a price-to-earnings ratio of -16.50 and a beta of 0.71. The company has a fifty day moving average of $0.44 and a 200 day moving average of $0.50. The company has a debt-to-equity ratio of 1.97, a quick ratio of 0.86 and a current ratio of 0.86.

Acura Pharmaceuticals Company Profile (Get Rating)

Acura Pharmaceuticals, Inc, an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products.

Further Reading

Receive News & Ratings for Acura Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acura Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.